Skip to content

Using state-of-the-art genetic sequencing techniques to find genes that cause limb-girdle muscular dystrophies 

Professor Henry Houlden from University College London (UCL), and colleagues from UCL and Newcastle University, will use state-of-the-art DNA sequencing techniques to identify genetic causes of limb-girdle muscular dystrophies in families who have no genetic diagnosis.
Details
Principal Investigator
Professor Henry Houlden
Institute
University College London (UCL)
Official title
Leveraging Long-Read Genome and Transcriptome Sequencing to Advance the Understanding of Limb-girdle Muscular Dystrophies
Duration
Three years
Total cost
£224,465
Conditions
Limb girdle muscular dystrophy (LGMD)
Year
2024

Background

Identifying the genes that cause a condition is essential to its effective management and treatment. Types of limb girdle muscular dystrophies (LGMD) are caused by changes in over 30 genes identified so far. However, despite continuous progress in ‘reading’ genes, called sequencing, around 50% of people with LGMD still remain genetically undiagnosed. This means there must be more genes in which changes can cause a form of LGMD.  

Professor Houlden and colleagues at UCL want to use advanced analysis of sequencing (called bioinformatics) with new techniques to sequence stretches of DNA (long-read genome sequencing) to overcome the limitations of previous sequencing techniques. This could help identify a number of causes of LGMD that relate to a person’s genetic information.  

What are the aims of the project?

The researchers will use bioinformatics to re-analyse strings of DNA (genetic sequences) of over 1500 people with LGMD to identify new, previously hidden genes that cause the condition. This will increase the rate of successful diagnoses. They will also sequence strings of DNA (long-read sequencing) to identify previously missed genetic causes of LGMD in another 90 families. 

The importance of this study

Identifying genes that cause muscular dystrophies such as LGMD, and understanding how the condition progresses at a very detailed, molecular level, is essential for developing effective treatments. The researchers aim to establish new gene testing with the NHS diagnostic laboratories, which will advance and speed up the diagnosis of these conditions across the UK and beyond. 

We’ve already made great progress.

But there is still so much that needs to be done. Together, we can change the future of muscle wasting conditions. Join us. Today.